Law360 Turns To Partner Charles R. Macedo For His Comments on NantKwest v. Lee:
Critics of the new rule, who say the approach will effectively foreclose one of the two appellate options created for trademark and patent applicants by Congress, would applaud such an outcome.
"You say the patent office was wrong, and you need to present new evidence to show how it’s wrong,” said Charles R. Macedo, a partner with Amster Rothstein & Ebenstein LLP who helped pen an amicus brief from the New York Intellectual Property Law Association criticizing the new USPTO position. “Then you prove that it’s wrong, spending a tremendous amount of money to do so. Then they still get to hit you with attorneys’ fees?"
Read the full article (subscription required)